Editor’s Note:
This digest does not usually include notice of the many market research products available about various segments of the vaccines market, but occasionally a study will provide important scaling data or other analysis we believe helpful to our readers as below. CVEP does not endorse any market research report per se or any market research firm.

Market Research: Vaccine Market – Global Forecasts To 2022
By Technology & Types, Trend Analysis By Various Classes – Live / Attenuated, Subunit, Toxoid, Conjugate, DNA, Recombinant Vector, Synthetic, Dendritic Vaccines And By Indications – Infectious Diseases, Cancer, Allergy, Diabetes, Cardiovascular Disease With Market Landscape Analysis
Excerpt of announcement
   “…The global vaccine technology market is anticipated to reach around US$84 billion by 2022, growing at a CAGR of 11.36%. The potential growth of the market is attributed towards therapeutic vaccines, allergy vaccines, and emerging-disease vaccines. Improved understanding of immunology, new technological breakthroughs in the development of a new class of vaccines, namely, recombinant vector vaccines, DNA vaccines, and dendritic vaccines coupled with excellent distribution channels are propelling the growth of this market. Furthermore, a large population base in emerging economies and a high prevalence of diseases is driving the market, which is expected to remain consistent in the coming years…
…The vaccine technology market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following issues: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022…
http://www.researchandmarkets.com/publication/m3iqw76/vaccine_market_by_technology_types_various